Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
Venu Krishna, Barclays Managing Director...
President Trump signs an executive order...
Mandy Xu, Cboe, joins 'Closing Bell Over...
Bloomberg’s Matt Miller takes a look at ...
----------------------------------------...
Electric bike startup Also, which spun o...
The number of people facing acute hunger...
Wearable company Whoop has topped a $10 ...
Autonomous military boat startup Saronic...
Adam Chamberlain, CEO of Mercedes-Benz U...
In his first interview since stepping do...
Systematic screening for U.S. companies ...
Investing Group Leader James Foord explo...